Cited by 3,533Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery SystemsDendrimers and Hyperbranched Polymers

Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives

Knop, Katrin, Hoogenboom, Richard, Fischer, Dagmar, Schubert, Ulrich S.·2010·Angewandte Chemie International Edition

Abstract

Poly(ethylene glycol) (PEG) is the most used polymer and also the gold standard for stealth polymers in the emerging field of polymer‐based drug delivery. The properties that account for the overwhelming use of PEG in biomedical applications are outlined in this Review. The first approved PEGylated products have already been on the market for 20 years. A vast amount of clinical experience has since been gained with this polymer—not only benefits, but possible side effects and complications have also been found. The areas that might need consideration and more intensive and careful examination can be divided into the following categories: hypersensitivity, unexpected changes in pharmacokinetic behavior, toxic side products, and an antagonism arising from the easy degradation of the polymer under mechanical stress as a result of its ether structure and its non‐biodegradability, as well as the resulting possible accumulation in the body. These possible side effects will be discussed in this Review and alternative polymers will be evaluated.

Integrity signals

Registry

Crossref · 10.1002/anie.200902672

Cites

219 of 219 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PEG immunogenicity depends on the degree of PEGylation to which the molecule it is coupled with, and PEG has been shown to induce unpredictable complement activation.

    “However, immunogenicity of PEG depends on the degree of PEGylation to which molecule it is coupled with and have been shown to induce unpredictable complement activation.[ 204 ]”
  • Incorporating PEG-lipids further decreases recognition by the MPS and clearance by renal filtration.

    “Incorporating PEG-lipids further decreases recognition by the MPS and clearance by renal filtration17,127.”

    From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [127]

  • Anti-PEG antibodies could result in fast systemic clearance of subsequently administered PEGylated nanoparticles by accelerated blood clearance.

    “Moreover, anti-PEG antibodies could result in fast systemic clearance of subsequently administered PEGylated nanoparticles by accelerated blood clearance127,169.”

    From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [127]

  • The accelerated blood clearance phenomenon may change the bioavailability and biodistribution of the drug encapsulated in PEGylated nanoparticles and cause side effects.

    “The accelerated blood clearance phenomenon may change the bioavailability and biodistribution of the drug encapsulated in PEGylated nanoparticles and, thus, cause side effects127,169.”

    From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [127]

  • Numerous natural and synthetic polymers have been investigated as alternatives to PEG, several of which are under evaluation in clinical trials.

    “To ameliorate safety concerns, numerous natural and synthetic polymers have been investigated as alternatives to PEG, of which several are under evaluation in clinical trials127,169.”

    From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [127]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S.
Affiliations
  • Dutch Polymer Institute (NL)
  • Friedrich Schiller University Jena (DE)
Venue
Angewandte Chemie International Edition
Publisher
Wiley
Published
2010-07-20
Volume
49
Issue
36
Pages
6288-6308
ISSN
  • 1433-7851 (ISSN-L)
  • 1521-3773
OpenAlex
W2164841185
Cited by
3,533
References
219
Citations by year
2026: 176 · 2025: 207 · 2024: 191 · 2023: 213 · 2022: 255 · 2021: 270 · 2020: 259 · 2019: 260 · 2018: 277 · 2017: 234 · 2016: 275 · 2015: 254 · 2014: 206 · 2013: 180 · 2012: 159
FWCI
7.02
Type
journal article
Language
en
Open access
closed
Locations
  • Angewandte Chemie International Edition (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • DIAL (Catholic University of Leuven) (submittedVersion)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
Keywords
polyethylene glycol, PEGylation, stealth polymers, polymeric drug delivery, hypersensitivity, pharmacokinetics, polymer degradation
MeSH terms
Biocompatible Materials, Drug Carriers, Pharmaceutical Preparations, Polyethylene Glycols, Polymers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review